Bausch Health Companies (BHC) Finished Goods (2012 - 2018)
Bausch Health Companies (BHC) reported Finished Goods of $564.0 million for Q4 2018, down 9.9% on a YoY basis from $626.0 million in Q4 2017, and down 3.42% sequentially from $584.0 million in Q3 2018.
Bausch Health Companies (BHC) Finished Goods (2012 - 2018) Analysis & Trends
Bausch Health Companies (BHC) has 7 years of Finished Goods data on file, last reported at $564.0 million in Q4 2018.
- For the quarter ending Q4 2018, Finished Goods fell 9.9% year-over-year to $564.0 million; the trailing twelve-month figure through Dec 2018 stood at $564.0 million (down 9.9% YoY), and the FY2018 full-year result was $564.0 million, down 9.9% from the prior year.
- Finished Goods retreated to $564.0 million in Q4 2018, from $584.0 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $843.0 million in Q2 2015 to a low of $564.0 million in Q4 2018.
- A 5-year average of $658.1 million and a median of $618.0 million in 2018 frame the typical range for Finished Goods.
- Across the five-year window, Finished Goods jumped 34.96% in 2015 and declined 16.56% in 2016, its largest moves.
- Tracing BHC's Finished Goods over 5 years: stood at $603.9 million in 2014, then jumped by 34.96% to $815.0 million in 2015, then retreated by 16.56% to $680.0 million in 2016, then decreased by 7.94% to $626.0 million in 2017, then decreased by 9.9% to $564.0 million in 2018.
- Business Quant data shows BHC's Finished Goods at $564.0 million in Q4 2018, $584.0 million in Q3 2018, and $589.0 million in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 564.00 Mn |
| Sep 30, 2018 | 584.00 Mn |
| Jun 30, 2018 | 589.00 Mn |
| Mar 31, 2018 | 618.00 Mn |
| Dec 31, 2017 | 626.00 Mn |
| Dec 31, 2016 | 680.00 Mn |
| Dec 31, 2015 | 815.00 Mn |
| Jun 30, 2015 | 843.00 Mn |
| Dec 31, 2014 | 603.90 Mn |
| Dec 31, 2013 | 656.30 Mn |
| Sep 30, 2013 | 824.27 Mn |
| Jun 30, 2013 | 358.10 Mn |
| Dec 31, 2012 | 406.02 Mn |